The Week Ahead: PepsiCo and Nvidia to Report Earnings
Big names in energy to report, and trade and production data will be released on Friday.
Big names in energy to report, and trade and production data will be released on Friday.
The week will begin with the earnings report from Allergan on Monday. Other companies with earnings announcements include CVS Health (CVS) and Cisco (CSCO) on Wednesday.
PepsiCo (PEP), which has a Morningstar Economic Moat Rating of wide, will be releasing earnings on Thursday. In December, the company announced its intention to acquire U.S. snack food company BFY Brands for an undisclosed amount. PepsiCo also announced last month that starting this year it will use 100% renewable electricity for all U.S. operations. This is part of its wider goal to become more sustainable and lower its greenhouse gas emissions.
In the energy sector, Dominion Energy (D), Duke Energy (DUK), and Enbridge (ENB) will report earnings on Tuesday, Thursday, and Friday, respectively.
The Minnesota Public Utilities Commission voted Monday to resume Enbridge's Line 3 pipeline replacement project after deeming a revised environmental assessment "adequate." The market has been responding positively to this news. Despite the resumption, the pipeline is still not expected to be operational until the end of 2021. Considering these factors, our analysts have reaffirmed their $47 fair value estimate and wide moat rating.
Nvidia (NVDA) will announce its earnings on Thursday. On Tuesday, Nvidia made a surprise launch of its cloud video-game streaming platform GeForce Now, available in both free and paid tiers. It is being launched as a competitor to Google's Stadia. The narrow-moat company, however, is still facing competitive pressure on pricing from Advanced Micro Devices (AMD) in the gaming sector, and our analysts maintain that Nvidia's shares are overvalued, with our fair value estimate remaining at $145.
Friday brings a slew of economic reports. This includes retail sales, export prices, import prices, industrial production, and capacity utilization reports for January. Business inventory reports for December 2019 will also be released on Friday.
Charlotte Frank does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.